User profiles for Maria Chiara Pelle

Maria Chiara Pelle

Università Magna Graecia di Catanzaro
Verified email at unicz.it
Cited by 355

[HTML][HTML] Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility

, … Domenico 8 Petullà Maria 8 Bertucci Bernardo 8 … - Scientific reports, 2020 - nature.com
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …

[HTML][HTML] Up-date on diabetic nephropathy

MC Pelle, M Provenzano, M Busutti, CV Porcu, I Zaffina… - Life, 2022 - mdpi.com
Diabetes is one of the leading causes of kidney disease. Diabetic kidney disease (DKD) is a
major cause of end-stage kidney disease (ESKD) worldwide, and it is linked to an increase …

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study

…, C Pelaia, E Lio, MT Busceti, MC Pelle… - Therapeutic …, 2020 - journals.sagepub.com
The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …

[HTML][HTML] Potential role of glucagon-like peptide-1 receptor agonists in the treatment of cognitive decline and dementia in diabetes mellitus

MC Pelle, I Zaffina, F Giofrè, R Pujia… - International Journal of …, 2023 - mdpi.com
Dementia is a permanent illness characterized by mental instability, memory loss, and
cognitive decline. Many studies have demonstrated an association between diabetes and …

[HTML][HTML] Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia

…, E Arrighi, F Serapide, MC Pelle… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Di Giambenedetto et al. 1 described their experience with intravenous tocilizumab
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …

[HTML][HTML] Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: from pathophysiology …

MC Pelle, M Provenzano, I Zaffina, R Pujia, F Giofrè… - Life, 2021 - mdpi.com
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
are two gut hormones, defined incretins, responsible for the amplification of insulin secretion …

[HTML][HTML] Endothelial dysfunction in COVID-19: potential mechanisms and possible therapeutic options

MC Pelle, I Zaffina, S Lucà, V Forte, V Trapanese… - Life, 2022 - mdpi.com
SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the
etiological agent of the current pandemic that is a heterogeneous disease, named coronavirus …

[HTML][HTML] COVID-19 and diabetes—Two giants colliding: From pathophysiology to management

MC Pelle, I Zaffina, M Provenzano… - Frontiers in …, 2022 - frontiersin.org
Since December 2019, a new coronavirus, called severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has spread around the world, causing the coronavirus 2019 (COVID-…

[HTML][HTML] Sodium-glucose co-transporter-2 inhibitors and nephroprotection in diabetic patients: more than a challenge

M Provenzano, MC Pelle, I Zaffina, B Tassone… - Frontiers in …, 2021 - frontiersin.org
Diabetic nephropathy is the most common cause of end-stage renal disease worldwide.
Control of blood glucose and blood pressure (BP) reduces the risk of developing this …

[HTML][HTML] Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical …

MC Pelle, B Tassone, M Ricchio, M Mazzitelli… - Journal of Medical Case …, 2020 - Springer
Background In December 2019, a new coronavirus (named severe acute respiratory syndrome
coronavirus 2, SARS-CoV-2) spread from China, causing a pandemic in a very short time…